logo
Clinical Trials of Vascular Disrupting Agents in Advanced Non-Small-Cell Lung Cancer
Scar Carcinoma of the Lung: A Historical Perspective
Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study
A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
The Role of NF-E2-Related Factor 2 in Predicting Chemoresistance and Prognosis in Advanced Non-Small-Cell Lung Cancer
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC)
Frameless Image-Guided Stereotactic Body Radiation Therapy for Lung Tumors with 4-Dimensional Computed Tomography or 4-Dimensional Positron Emission Tomography/ Computed Tomography
A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer
Clinical Value of Assaying Tumor Supplied Group of Factor/Tumor Specific Growth Factor in Patients With Solitary Pulmonary Nodule
Prognostic Implications of Parathyroid Hormone-Related Protein in Males and Females With Non-Small-Cell Lung Cancer